Allos Therapeutics, Inc. to Present at the RBC Capital Markets 2008 Healthcare Conference

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company’s senior management will participate in a panel presentation, “Waging a Battle Against Cancer,” at the RBC Capital Markets 2008 Healthcare Conference.

Back to news